Shortened postpartum magnesium sulfate treatment vs traditional 24h for severe preeclampsia: a systematic review and meta-analysis of randomized trials
Authors:
- 2 April 2020
- journal article
- review article
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 39 (2) , 186-195
Abstract
Objectives: This meta-analysis aimed to compare the benefits and risks of shortened magnesium sulfate with traditional 24 h for severe postpartum preeclampsia. Methods: We systematically searched the Cochrane, Embase, Web of science and Pubmed database from inception till May 15 2019. Studies included type is limited to randomized controlled trial (RCT). Pooled risks difference (RDs), odds risks (ORs), mean difference (MD), standard mean difference (SMD) and 95% confifidence intervals (CIs) were used to summarize the effect sizes. Results: Totally studies included are 7 randomized controlled trials (RCTs). Shortened magnesium sulfate treatment has the same risk as eclampsia (RD 0.00, 95%CI-0.01–0.01) and total complications (OR 0.78, 95% CI 0.53–1.15), however, significant difference was observed in both groups pertaining to flushing (OR 0.40, 95% CI 0.20–0.82), and the need for prolonged treatment (RD 0.05, 95% CI 0.01 − 0.1), Others factors,namely the benefits of shortened magnesium sulfate treatment,showed differences in both groups. Conclusions: Shortened postpartum magnesium sulfate treatment was as effective as traditional 24 h magnesium sulfate in seizure prevention and total complications. But flushing and needed for prolonged treatment in the shortened groups warrants further research.Keywords
Funding Information
- Natural Science Foundation of China (No. 81471498)
This publication has 21 references indexed in Scilit:
- 12-Hour Compared With 24-Hour Postpartum Magnesium Sulfate Therapy in PreeclampsiaObstetrics & Gynecology, 2014
- Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic reviewBMC Pregnancy and Childbirth, 2013
- A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world useInternational Journal of Gynecology & Obstetrics, 2012
- A shortened postpartum magnesium sulfate prophylaxis regime in pre‐eclamptic women at low risk of eclampsiaInternational Journal of Gynecology & Obstetrics, 2012
- A randomised comparative study between low-dose intravenous magnesium sulphate and standard intramuscular regimen for treatment of eclampsiaJournal of Obstetrics and Gynaecology, 2011
- Abbreviated Postpartum Magnesium Sulfate Therapy for Women With Mild PreeclampsiaObstetrics & Gynecology, 2006
- A prospective randomized trial of magnesium sulfate in severe preeclampsia: Use of diuresis as a clinical parameter to determine the duration of postpartum therapyAmerican Journal of Obstetrics and Gynecology, 2005
- Strategies to prevent and treat preeclampsia: Evidence from randomized controlled trialsSeminars in Nephrology, 2004
- Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trialsAmerican Journal of Obstetrics and Gynecology, 2004
- Postpartum seizure prophylaxis: using maternal clinical parameters to guide therapyObstetrics & Gynecology, 2003